Cancer Genetics Group

The only way to halt the epidemic of e-cigarette use among young people is to significantly strengthen enforcement of existing laws and enact additional legislative controls. Read the recommendations from Cancer Council, COSA and other leading public health organisations.

This position statement recommends the development of a national strategy of universal dMMR tumour screening in all newly diagnosed colorectal and endometrial cancers. This will allow the identification of families with Lynch Syndrome, as well as inform the clinical care of cancer patients. We recognise the need for education of clinicians and the public about Lynch Syndrome, and the provision of adequate laboratory and clinical genetics resources to enable full ascertainment of Australian Lynch Syndrome families and realise the individual and population-level health benefits of their ascertainment.

The Cancer Australia Statement – Influencing best practice in breast cancer is a summary of 12 practices that have been identified as appropriate or inappropriate for the provision of breast cancer care in Australia.

The purpose of the Statement is to support improved, evidence-informed decisions for cancer care and to engage consumers in their care. While many patients with metastatic breast cancer are living longer, current treatments for metastatic breast cancer are generally not curative. The main treatment goals for metastatic breast cancer are to effectively manage symptoms and optimise quality of life, as well as to prolong survival.

A tool to help women and their clinical collaboratively assess and manage breast cancer risk

The Human Genetics Society of Australasia (HGSA) is a COSA Affiliated Organisation. HGSA was formed in 1977 to provide a forum for the various disciplines collected under the title of Human Genetics

The COSA Fertility Preservation Guidelines Working Group has developed these guidelines to assist health professionals discuss and manage fertility preservation for people with cancer in Australia.